2024
Pathogenesis and therapeutic opportunities of gut microbiome dysbiosis in critical illness.
Gut Microbes 2024;16(1):2351478. | PMID: 38780485 | DOI : 10.1080/19490976.2024.2351478
Gut Microbes 2024;16(1):2351478. | PMID: 38780485 | DOI : 10.1080/19490976.2024.2351478
2023
Dysbiosis of a microbiota-immune metasystem in critical illness is associated with nosocomial infections.
Nat Med 2023;29(4):1017-1027. | PMID: 36894652 | DOI : 10.1038/s41591-023-02243-5
Nat Med 2023;29(4):1017-1027. | PMID: 36894652 | DOI : 10.1038/s41591-023-02243-5
Vascular traffic control of neutrophil recruitment to the liver by microbiota-endothelium crosstalk.
Cell Rep 2023;42(5):112507. | PMID: 37195866 | DOI : 10.1016/j.celrep.2023.112507
Cell Rep 2023;42(5):112507. | PMID: 37195866 | DOI : 10.1016/j.celrep.2023.112507
2022
Long-distance relationships - regulation of systemic host defense against infections by the gut microbiota.
Mucosal Immunol 2022;15(5):809-818. | PMID: 35732817 | DOI : 10.1038/s41385-022-00539-2
Mucosal Immunol 2022;15(5):809-818. | PMID: 35732817 | DOI : 10.1038/s41385-022-00539-2
A functionally distinct neutrophil landscape in severe COVID-19 reveals opportunities for adjunctive therapies.
JCI Insight 2022;7(2):e152291. | PMID: 34908534 | DOI : 10.1172/jci.insight.152291
JCI Insight 2022;7(2):e152291. | PMID: 34908534 | DOI : 10.1172/jci.insight.152291